Drugs, Pills | featured news

The new class of drug, which can be taken orally, is designed to protect the brain by combating the damaging effects of inflammation. Results from early stage clinical trials have yet to be announced, but studies on animals suggest the therapy could be effective against a wide range of conditions which also include motor neurone disease and complications from traumatic brain injury.

Federal health regulators have decided not to approve an experimental diet pill called Qnexa, which had been touted by many experts as the most promising weight-loss drug in more than a decade.